SIRT7 promotes lung cancer progression by destabilizing the tumor suppressor ARF
Kumari, Poonam (Max-Planck-Institute for Heart and Lung Research. Department of Cardiac Development and Remodeling)
Tarighi, Shahriar (Max-Planck-Institute for Heart and Lung Research. Department of Cardiac Development and Remodeling)
Fuchshuber, Eva (Max-Planck-Institute for Heart and Lung Research. Department of Cardiac Development and Remodeling)
Li, Luhan (Nankai University)
Fernández-Duran, Irene (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Wang, Meilin (Nankai University)
Ayoson, Joshua (Max-Planck-Institute for Heart and Lung Research. Department of Cardiac Development and Remodeling)
Castelló-García, Jose Manuel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Gámez-García, Andrés (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Espinosa-Alcantud, María Dolores (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Sreenivasan, Krishnamoorthy (Max-Planck-Institute for Heart and Lung Research. Department of Cardiac Development and Remodeling)
Guenther, Stefan (Max-Planck-Institute for Heart and Lung Research. Department of Cardiac Development and Remodeling)
Olivella, Mireia (Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central)
Savai, Rajkumar (Justus Liebig University)
Yue, Shijing (Nankai University)
Vaquero, Alejandro (Max-Planck-Institute for Heart and Lung Research. Department of Cardiac Development and Remodeling)
Braun, Thomas (Max-Planck-Institute for Heart and Lung Research. Department of Cardiac Development and Remodeling)
Ianni, Alessandro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)

Fecha:	2024
Resumen:	Sirtuin 7 (SIRT7) is a member of the mammalian family of nicotinamide adenine dinucleotide (NAD)-dependent histone/protein deacetylases, known as sirtuins. It acts as a potent oncogene in numerous malignancies, but the molecular mechanisms employed by SIRT7 to sustain lung cancer progression remain largely uncharacterized. We demonstrate that SIRT7 exerts oncogenic functions in lung cancer cells by destabilizing the tumor suppressor alternative reading frame (ARF). SIRT7 directly interacts with ARF and prevents binding of ARF to nucleophosmin, thereby promoting proteasomal-dependent degradation of ARF. We show that SIRT7-mediated degradation of ARF increases expression of protumorigenic genes and stimulates proliferation of non-small-cell lung cancer (NSCLC) cells both in vitro and in vivo in a mouse xenograft model. Bioinformatics analysis of transcriptome data from human lung adenocarcinomas revealed a correlation between SIRT7 expression and increased activity of genes normally repressed by ARF. We propose that disruption of SIRT7-ARF signaling stabilizes ARF and thus attenuates cancer cell proliferation, offering a strategy to mitigate NSCLC progression.
Ayudas:	European Commission 101065013 Agencia Estatal de Investigación PID2020-117284RB-I00
Derechos:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Lengua:	Anglès
Documento:	Article ; recerca ; Versió publicada
Materia:	ARF ; SIRT7 ; Sirtuins ; Lung cancer ; Nucleophosmin
Publicado en:	Proceedings of the National Academy of Sciences of the United States of America, Vol. 121 Núm. 25 (June 2024) , ISSN 1091-6490

DOI: 10.1073/pnas.2409269121
PMID: 38870055

12 p, 9.6 MB

El registro aparece en las colecciones:
Documentos de investigación > Documentos de los grupos de investigación de la UAB > Centros y grupos de investigación (producción científica) > Ciencias de la salud y biociencias > Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP) > Instituto de Investigación contra la Leucemia Josep Carreras
Artículos > Artículos de investigación
Artículos > Artículos publicados